Nascent drug maker Cytochroma, of Markham, Ontario, which focuses on identifying small molecules that target cytochrome P450 gene mutations, said it has uncovered a gene that metabolizes 9-cis retinoic acid.
The gene, CYP26C, is generally understood to be the third member of the CYP450 gene family, which metabolize all-trans retinoic acid. The other two genes, CYP26A and CYP26B, do not do this.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
